Northwestern researchers report that silencing somatostatin neurons in the mouse central amygdala reduced cannabinoid-heightened fear of fox odor. With a synthetic drug and genetic silencing, the circuit is a lead on cannabis-linked panic, several steps from any human treatment.
Reality
- Evidence55
- Adoption
- Insufficient
- Hype gap+35
- Incentives
- Insufficient
- Confidence60
The WashU group reports in Nature that the structures activate in mice before distant lymph nodes get the signal, and that a gel of three immune proteins placed under the scalp boosted the antitumor response.
Reality
- Evidence52
- Adoption
- Insufficient
- Hype gap+30
- Incentives68
- Confidence55
The claim out of Stanford Medicine is that tissue-resident macrophages stop clearing dying neutrophils as animals age. Disabling one receptor on those macrophages spared mice frailty, fat gain and heart trouble.
Reality
- Evidence36
- Adoption
- Insufficient
- Hype gap+44
- Incentives68
- Confidence41
A Yale mouse study in PNAS reports that semaglutide activates AgRP neurons, and that animals lacking those neurons cannot sustain fat loss on the drug.
Reality
- Evidence44
- Adoption
- Insufficient
- Hype gap+34
- Incentives62
- Confidence46
In mice, a peptide-PEG agent given before dosing cut liver expression several dozenfold and raised spleen expression severalfold, according to work in ACS Nano.
Reality
- Evidence30
- Adoption12
- Hype gap+28
- Incentives62
- Confidence38
A Cambridge mouse study locates the GIP paradox in anatomy: agonists act through the brainstem, antagonists release a hypothalamic brake. Combination design becomes a targeting question.
Reality
- Evidence52
- Adoption34
- Hype gap+22
- Incentives62
- Confidence50